GNLN vs. MEDS, JXJT, WTER, BIMI, CUEN, AENTW, CHSCP, CHSCO, CHSCN, and CHSCM
Should you be buying Greenlane stock or one of its competitors? The main competitors of Greenlane include TRxADE HEALTH (MEDS), JX Luxventure (JXJT), Alkaline Water (WTER), BIMI (BIMI), Cuentas (CUEN), Alliance Entertainment (AENTW), CHS (CHSCP), CHS (CHSCO), CHS (CHSCN), and CHS (CHSCM). These companies are all part of the "wholesale" industry.
Greenlane vs.
TRxADE HEALTH (NASDAQ:MEDS) and Greenlane (NASDAQ:GNLN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, community ranking, analyst recommendations, valuation, institutional ownership and dividends.
TRxADE HEALTH has higher earnings, but lower revenue than Greenlane.
In the previous week, Greenlane had 1 more articles in the media than TRxADE HEALTH. MarketBeat recorded 1 mentions for Greenlane and 0 mentions for TRxADE HEALTH. Greenlane's average media sentiment score of 0.72 beat TRxADE HEALTH's score of 0.00 indicating that Greenlane is being referred to more favorably in the news media.
5.7% of TRxADE HEALTH shares are held by institutional investors. Comparatively, 14.0% of Greenlane shares are held by institutional investors. 48.4% of TRxADE HEALTH shares are held by company insiders. Comparatively, 0.0% of Greenlane shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Greenlane received 66 more outperform votes than TRxADE HEALTH when rated by MarketBeat users. Likewise, 58.78% of users gave Greenlane an outperform vote while only 52.50% of users gave TRxADE HEALTH an outperform vote.
TRxADE HEALTH has a beta of 2.32, suggesting that its share price is 132% more volatile than the S&P 500. Comparatively, Greenlane has a beta of 1.89, suggesting that its share price is 89% more volatile than the S&P 500.
Greenlane has a net margin of -61.25% compared to TRxADE HEALTH's net margin of -149.81%. Greenlane's return on equity of -162.15% beat TRxADE HEALTH's return on equity.
Summary
Greenlane beats TRxADE HEALTH on 9 of the 13 factors compared between the two stocks.
Get Greenlane News Delivered to You Automatically
Sign up to receive the latest news and ratings for GNLN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Greenlane Competitors List
Related Companies and Tools
This page (NASDAQ:GNLN) was last updated on 3/30/2025 by MarketBeat.com Staff
